I am the beauty industry editor at QuickOEM, and this is the topic where I see brands lose the most money. Not on formulation, and not on packaging — on the sentence somebody wrote on the carton. The question I get most often sounds like this: "My serum says 'brightens and smooths fine lines, visible in 28 days'. My factory said the filing would pass, but a competitor challenged the listing and Amazon pulled it. Whose fault is that?"

The answer is uncomfortable and unambiguous: the claim is the brand's responsibility. A contract manufacturer produces a safe, compliant formula and supports the filing. The words belong to the party whose name is on the label. In the United States, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) put that in statutory language by defining a Responsible Person and giving that person an explicit duty to hold safety substantiation. Below is the path, in the order a US brand or importer should actually walk it.

Step 1 — Name the Responsible Person and appoint the US Agent

Everything downstream depends on two names.

The Responsible Person is the manufacturer, packer or distributor whose name appears on the cosmetic label. If you private label, that is you — not your factory, not your 3PL, not your agency. The Responsible Person must ensure the product's safety is adequately substantiated before it goes to market, and must maintain the records supporting that conclusion.
The US Agent, if any facility in your supply chain manufactures outside the United States. MoCRA requires foreign cosmetic facilities to designate a US-based agent as part of registration. That agent receives FDA communications, is listed on the registration, and is the practical point of contact if FDA opens a question about your supply chain.

Put both in writing before the first purchase order. A foreign facility without a designated US Agent is not properly registered, and "we assumed the factory handled it" is not a defense you want to be making in a response letter.

There is a narrow small-business carve-out: facilities whose responsible person had average annual gross sales below the statutory threshold over the preceding three-year period are exempt from facility registration, product listing and good manufacturing practice requirements. Two cautions. The exemption is administrative and does not relieve you of the duty to hold safety substantiation, to report serious adverse events, or to label correctly. And it does not cover every product category — FDA may disapply it for certain higher-risk product types. Confirm the current statutory text with counsel before relying on it.

Step 2 — Register the facility, list every product and keep the calendar current

Obligation	What it covers	Timing	Renewal
Facility registration	Each facility that manufactures or processes cosmetic products for the US market	Within 60 days of beginning operations for a new facility; biennial renewal thereafter	Every two years
Product listing	Each marketed cosmetic product, submitted by the Responsible Person, including ingredients	Within 120 days of the product being marketed	Annually
US Agent designation	Required for every foreign facility in the registration	At the time of registration	Maintained with the registration
Safety substantiation	Adequate evidence that the product is safe under labelled or customary conditions of use	Before market entry — not after	Kept current as the formula changes
Serious adverse event reporting	Reports received by the Responsible Person	Within 15 business days of receipt	Ongoing
Record retention	The records supporting safety substantiation	Six years, shortened to three for qualifying small businesses	Ongoing
Label contact information	A domestic address, telephone number or electronic contact for reporting adverse events must appear on the label	At market entry	Maintained

Two details brands routinely miss. First, an annual facility registration fee is set by FDA each fiscal year; the amount moves with the Federal Register notice, so budget against the current year rather than a number you read in a blog post. Second, listing is per marketed product, not per brand — every shade, every size, every formula revision that changes the ingredient list needs its own listing and its own renewal. Build that into your SKU planning, because a launch of twelve shades is twelve listing records to maintain.

None of this is a launch task — it is a calendar, and the calendar is where brands quietly fall out of compliance:

Annual listing renewal. Diary it with the SKU count and assign an owner. A lapsed listing is an avoidable finding.
Biennial facility registration renewal, plus the annual FDA fee.
Formula-change trigger. Any change to the ingredient list, the preservative system or the manufacturing site invalidates part of your file. Re-check substantiation before you re-print cartons.
Adverse event SOP. Log the report the day it arrives, assess whether it meets the serious-adverse-event criteria, and file within 15 business days. Retain records for six years. Make sure the contact information on the label routes to a monitored inbox — a label that sends reports to an unmonitored mailbox is a finding waiting to happen.
Claim audit twice a year. Pull every claim on the website, the listing, the carton, the insert and the affiliate brief, and reconcile each one against the file. The copy drifts; the file does not.

Step 3 — Decide whether your claim is a cosmetic claim or a drug claim

This is the highest-value decision in the whole process, and it is made entirely with words. Under the Federal Food, Drug, and Cosmetic Act, a cosmetic is intended to cleanse, beautify, promote attractiveness or alter the appearance. A drug is intended to diagnose, cure, mitigate, treat or prevent disease, or to affect the structure or any function of the body. Intended use is judged by the claims, and — under FDA's revised approach to intended use — by a product's design and composition as well.

Cosmetic framing — stay here	Drug framing — this changes your regulatory category
Reduces the appearance of fine lines	Stimulates collagen production
Hydrates and plumps the look of skin	Repairs the skin barrier (a physiological repair claim)
Brightens the look of dull skin	Treats melasma or hyperpigmentation
Soothes redness-prone skin	Treats eczema, rosacea or acne
Helps absorb excess oil	Treats acne vulgaris
Protects against environmental stressors	Prevents photoaging or UV-induced DNA damage
Calms the feel of sensitive skin	Reduces inflammation

Three categories deserve a specific warning, because they surprise people every season:

Sunscreens are OTC drugs in the United States. They require a Drug Facts panel, monograph-compliant or NDA-approved actives, and prescribed SPF testing. A moisturizer with SPF is still a drug. This is also true in Australia, where sunscreens are regulated by the TGA as therapeutic goods rather than as cosmetics.
Acne claims are drug claims. Benzoyl peroxide and salicylic acid are OTC drug actives under FDA's topical acne monograph. "Helps keep pores clear" is cosmetic positioning; "treats acne" is a drug claim that requires the monograph pathway.
Mechanism language is a trap. "Stimulates collagen", "boosts cellular turnover", "repairs DNA" all describe effects on the body's structure or function. Marketers love mechanism language because it sounds scientific; that is exactly why it converts a cosmetic into an unapproved new drug.

Step 4 — Build the substantiation file: what counts as evidence

There is no FDA pre-approval of a cosmetic claim, which means the file is yours to build and yours to defend. Rank your evidence the way a regulator or a NAD panel will.

Tier	What it is	How much weight it carries
1. Randomised, controlled human trials on the finished product	The gold standard, rarely affordable for an indie launch	Highest. This is what the FTC Health Products Compliance Guidance generally expects for claims about treating or preventing disease or affecting the body's structure or function in a disease-relevant way
2. Controlled clinical testing on the finished product	Instrumental measurement (corneometry, TEWL, chromametry, cutometry, 3D profilometry) plus expert grading, with a defined panel and duration	Strong. This is the realistic target for an efficacy claim
3. Consumer perception studies (in-home use tests)	Structured questionnaires after 2 to 8 weeks of real use	Supports perception claims only: "81% said their skin looked smoother". It cannot support a measured claim
4. In vitro and ex vivo testing	Cell cultures, reconstructed skin models, antioxidant assays	Supporting only. Never the sole basis for a performance claim
5. Literature on the individual ingredient at the level you use	Published studies on niacinamide, peptides, and so on	Necessary but insufficient. Ingredient data does not prove the finished formula delivers it
6. Supplier brochures and raw-material datasheets	Marketing collateral	Not evidence. Useful for formulation decisions only

The common failure is tier six presented as tier two. A supplier's study on a peptide solution is not a study on your cream — different base, different pH, different preservative system, different penetration environment. If you rely on it, say so honestly and frame the claim at the level the evidence supports: "formulated with 5% acetyl hexapeptide-8", not "clinically proven to erase wrinkles".

Step 5 — Commission the right studies, at the right cost

Budget planning ranges in USD, for a US launch. Your laboratory, panel size and endpoints will move these numbers; they are here to stop you discovering the cost after you have committed to a launch date.

Study	What it substantiates	Typical duration	Budget planning range
HRIPT (human repeat insult patch test)	Irritation and sensitization — part of safety substantiation	6 – 8 weeks	$5,000 – $15,000
In-use tolerance test on sensitive or targeted skin populations	"Dermatologist-tested", "suitable for sensitive skin"	4 – 8 weeks	$5,000 – $15,000
Consumer perception study (IHUT)	Percentage-of-users perception claims	4 – 8 weeks	$8,000 – $25,000
Instrumental clinical study (hydration, TEWL, elasticity, tone)	Measured claims: "clinically shown to improve hydration for 24 hours"	4 – 12 weeks	$20,000 – $60,000
Expert visual grading (dermatologist scoring, photographic protocol)	Wrinkle, firmness and tone claims	Added to the study above	$5,000 – $15,000
SPF and UVA testing	Required for sunscreens	4 – 10 weeks	$10,000 – $40,000
Stability and preservative efficacy (ISO 11930)	Shelf life and safety in pack	12 – 14 weeks elapsed	$2,500 – $7,000

Practical sequencing: run HRIPT and stability in parallel with sampling, then commission the efficacy study once the formula is locked. Testing a formula you are still changing is the most expensive way to save four weeks.

And write the result the way the study was designed. "Clinically tested" tells a consumer nothing — not the panel size, not the endpoint, not the comparator. As Dr. Dray has said on the record: "When a brand says 'clinically tested', that tells you almost nothing." Write "in a 4-week clinical study of 42 participants, measured hydration increased by an average of 38%" and you have a claim that is both more persuasive and defensible.

Step 6 — Pressure-test the copy against FTC, NAD and retailer rules

The Federal Trade Commission enforces truth-in-advertising under Section 5, and the National Advertising Division of BBB National Programs runs the self-regulatory challenge process that most beauty disputes pass through first. Both apply the same core standard: competent and reliable scientific evidence, held before the claim runs.

Risky language	Safer replacement	Why
Clinically proven	In a 4-week study of N participants, [specific measured result]	"Proven" asserts far more than most studies support
Anti-aging / reverses aging	Reduces the appearance of fine lines and wrinkles	Ageing is a structural process; appearance is cosmetic
100% natural / chemical-free	No such claim, or state the specific standard you meet	Both have drawn class actions; "chemical-free" is also literally false
Clean / non-toxic	No legal or scientific definition. Use a named standard instead	Undefined superiority claims are a plaintiff's favorite
Made in USA	Only if all or virtually all of the product is US-sourced and manufactured	The FTC standard is strict, and the Made in USA rule carries civil penalties per violation, adjusted annually for inflation
Dermatologist-recommended	Only with a survey that meets FTC standards	Otherwise it is an unsubstantiated endorsement claim
Cures / treats / heals	Remove entirely	These convert a cosmetic into an unapproved drug

Run one more pass for the channel, because the platforms are stricter than the statute:

Amazon can suppress a listing without a hearing. Avoid disease references, keep the title factual, and make sure the carton, the listing and your study file all agree.
Shopify DTC rewards full disclosure — panel size, duration, method, result. That level of transparency is exactly how The Ordinary and Paula's Choice built trust with INCI-reading consumers.
Sephora and Ulta Beauty run ingredient and claim reviews, and Ulta's Conscious Beauty program applies its own restricted-substance and attribute criteria. Retailer paperwork belongs on the critical path before launch, not after.
TikTok Shop enforces health-claim rules at the creator level. If your affiliate brief says "gets rid of wrinkles", the creator will say it on camera and you will own the consequence. Brief in the words you have substantiated, and forbid the rest in writing.

Step 7 — Add the EU, UK and Australia layer

If you sell beyond the US, the US file is a starting point, not a passport.

Market	Governing claim framework	Held by	Distinctive requirement
European Union	Regulation (EU) 655/2013 — six common criteria: legal compliance, truthfulness, evidential support, honesty, fairness, informed decision-making	The EU Responsible Person, in the Product Information File, retained ten years after the last batch	The PIF must contain proof of the claimed effect where justified by the nature of the effect. "Free-from" claims may not imply that permitted ingredients are unsafe. Over 1,600 substances are prohibited under Annex II, against roughly a dozen at US federal level
United Kingdom	The same six criteria, applied under the retained UK regime and enforced through the CAP Code and Advertising Standards Authority	The UK Responsible Person, with a UK Product Information File	An EU dossier does not transfer. You need a UK Responsible Person and a separate notification
Australia	Australian Consumer Law — a strict-liability prohibition on misleading or deceptive conduct	The Australian sponsor or importer	Ingredient introductions run through AICIS and must be on the AIIC inventory. Sunscreens are therapeutic goods regulated by the TGA, not cosmetics

That contrast is the single most useful thing for a US-trained founder to internalise. The US is a post-market, self-substantiating system: no one approves your claim, but you must already hold the evidence and you will be judged after the fact by the FTC, by NAD, and increasingly by class action firms. The EU is a pre-notification system with a very long prohibited list: a named Responsible Person signs a safety report before you sell, and the ingredient rules are far broader than anything in the US. One Shopify storefront serving all four markets with one claim set is how brands end up with a takedown in a market they did not know they were selling into.

Budget and timeline at a glance

Phase	What happens	Working window	Planning budget
Formula lock and sampling	Stock base selection or modification, samples from the factory	7 – 30 days	Factory sampling fees, usually credited against the order
Safety package	HRIPT, tolerance testing, stability, preservative efficacy	12 – 16 weeks	$10,000 – $25,000
Efficacy package	Instrumental clinical study plus expert grading	8 – 16 weeks	$20,000 – $60,000
Regulatory admin	Facility registration, US Agent, product listings, label review	2 – 6 weeks	FDA annual fee per facility plus professional review
Retail readiness	Retailer ingredient and claim review	4 – 12 weeks, running in parallel	Included in the above

Total, a defensible US launch of a single hero SKU typically sits in the $35,000 to $100,000 band above the cost of goods, and takes roughly four to six months from formula lock. Brands that skip the middle two rows save money twice — once at launch, and once again when the challenge arrives.

QuickOEM landing plan

QuickOEM connects global beauty brands with more than 500 vetted Chinese cosmetic manufacturers, and the factories in our network understand that a claim file is a deliverable, not an afterthought.

MOQ: 500 – 1,000 units per SKU, with tiered pricing as you scale
Sampling: 7 – 15 days from stock bases; 20 – 30 days with modification
Mass production: 30 – 45 days after sample sign-off
Documentation we coordinate: ISO 22716 (GMP) manufacturing, COA and raw-material traceability, safety assessment support, ISO 11930 preservative efficacy, stability and packaging compatibility data, and the study panels your claim needs — HRIPT, tolerance, consumer perception and instrumental clinical work through partner laboratories
Where we help most: getting your Responsible Person obligations straight before you print, including the US Agent question for foreign facilities and the ingredient checks that differ between the US, EU, UK and Australian lists

Send us your formula direction, your target claim and your market list. We will match you with factories whose documentation will survive a challenge. Start at www.quickoem.com.

Educational content for brand owners, not legal advice. Confirm your obligations against the current statutory and regulatory text, and use qualified regulatory counsel for any claim that sits near the drug boundary or for market entry outside your home jurisdiction.

Cosmetic Claim Substantiation: A US MoCRA Compliance How-To